End-of-day quote
Korea S.E.
03:30:00 28/06/2024 am IST
|
5-day change
|
1st Jan Change
|
3,485
KRW
|
+2.80%
|
|
+8.74%
|
+13.33%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,89,087
|
1,82,777
|
1,85,487
|
64,666
|
Enterprise Value (EV)
1 |
2,79,938
|
1,57,595
|
1,79,176
|
61,976
|
P/E ratio
|
-61.1
x
|
-40.2
x
|
-13.5
x
|
-3.18
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
569
x
|
317
x
|
41.7
x
|
14.5
x
|
EV / Revenue
|
551
x
|
273
x
|
40.3
x
|
13.9
x
|
EV / EBITDA
|
-65.6
x
|
-24.2
x
|
-17.2
x
|
-4.53
x
|
EV / FCF
|
-
|
1,60,42,468
x
|
-1,33,93,766
x
|
-21,45,306
x
|
FCF Yield
|
-
|
0%
|
-0%
|
-0%
|
Price to Book
|
16.8
x
|
11
x
|
49.2
x
|
3.44
x
|
Nbr of stocks (in thousands)
|
13,091
|
13,374
|
14,043
|
21,029
|
Reference price
2 |
22,083
|
13,667
|
13,208
|
3,075
|
Announcement Date
|
18/03/22
|
18/03/22
|
20/03/23
|
21/03/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
507.9
|
577.1
|
4,445
|
4,453
|
EBITDA
1 |
-4,270
|
-6,501
|
-10,415
|
-13,683
|
EBIT
1 |
-4,554
|
-7,236
|
-11,697
|
-15,248
|
Operating Margin
|
-896.78%
|
-1,253.81%
|
-263.16%
|
-342.42%
|
Earnings before Tax (EBT)
1 |
-4,383
|
-4,942
|
-15,003
|
-17,382
|
Net income
1 |
-4,383
|
-4,697
|
-14,303
|
-16,035
|
Net margin
|
-863.09%
|
-813.94%
|
-321.79%
|
-360.1%
|
EPS
2 |
-361.2
|
-340.4
|
-977.7
|
-967.4
|
Free Cash Flow
|
-
|
9,824
|
-13,378
|
-28,889
|
FCF margin
|
-
|
1,702.28%
|
-300.97%
|
-648.78%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/03/22
|
18/03/22
|
20/03/23
|
21/03/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
9,149
|
25,182
|
6,312
|
2,690
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
9,824
|
-13,378
|
-28,889
|
ROE (net income / shareholders' equity)
|
-
|
-35.5%
|
-120%
|
-136%
|
ROA (Net income/ Total Assets)
|
-
|
-14.6%
|
-15.6%
|
-27.3%
|
Assets
1 |
-
|
32,200
|
91,626
|
58,804
|
Book Value Per Share
2 |
1,314
|
1,238
|
268.0
|
895.0
|
Cash Flow per Share
2 |
932.0
|
2,889
|
967.0
|
32.90
|
Capex
1 |
158
|
1,355
|
1,267
|
719
|
Capex / Sales
|
31.11%
|
234.77%
|
28.5%
|
16.15%
|
Announcement Date
|
18/03/22
|
18/03/22
|
20/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +13.33% | 51.43M | | -11.78% | 11.41B | | -13.76% | 7.4B | | +29.50% | 5.64B | | -0.19% | 5.33B | | -19.19% | 3.7B | | +7.62% | 2.58B | | -65.24% | 2.38B | | -10.48% | 2.2B | | +27.80% | 2.2B |
Diagnostic & Testing Substances
|